July 1, 2019

A long-awaited vote on an important decision

The European Commission’s vote postponed

On the coming 9th and 10th July, upon the REACH Committee, the European Commission was to vote on the CTAC decision (CTAC stands for Chromium Trioxide Authorisation Consortium), eagerly awaited. However, following ongoing internal discussions, in particular with the DG (Directorate-General) Environment and the DG Internal Market on the draft of the decision, the vote was postponed to a later date. The next REACH Committee is scheduled for 17th and 18th September 2019, dates on which the vote should theoretically take place.

History of the decision: a reminder

As a reminder, on 14th and 15th February 2019, the REACH Committee had already voted and adopted the “CTAC decision”, granting the authorisation to the consortium. Following this vote, one of the applicants proceeded to a legal entity change.

This change forced the REACH Committee to vote again on the decision. In the meantime, two events happened and influenced the process:

  • The General Court ruling which annuls an authorisation granted in 2016 for 6 uses of lead chromate
  • The European Parliament resolution criticising the CTAC decision of the European Commission

These two occurrences shed a new light on the situation, and the discussions are still underway.

CTAC authorisation consortium

CTAC is a consortium composed of 6 companies aiming at obtaining an authorisation for various uses of chromium trioxide. As long as the decision on the review period is still pending, the use of chromium trioxide for these companies is still authorised.

But, depending the European Commission’s decision, which will not be less restrictive than the one decided upon in February, things might change quickly. Since the authorisation covers downstream users as well, a very large number of companies could be affected: around 1 500 production sites.

Wish to know more more on REACH Authorisation?

For more information, do not hesitate to contact our expert Fangh Zhou by phone: +33 1 83 64 20 54 for Europe or +1 (778) 234 1607 for North America or even by mail at contact@ecomundo.eu.

Related articles

vignette blog

Downstream user Authorisations: ECHA’s answers

ECHA provided details on applications for authorisations submitted by downstream users already covered by an...Read more

vignette blog

REACH Authorisation: 4 key aspects for the Analysis of Alternatives

The REACH regulation allows companies to ask for an authorisation in order to be able to keep using substances...Read more

vignette blog

The 4 mainstays of a successful REACH Authorisation request

After nearly a dozen dossiers submitted to ECHA, EcoMundo has accumulated a huge know-how in Authorisation...Read more

Encore +

Articles similaires

Autorisation Reach

Postponement of the DEHP ban in medical devices: new dates

The European Commission recently announced a postponement of the ban on the use of bis(2-ethylhexyl) phthalate (DEHP) in medical devices (MDs).

The European Commission Approves Chrysanthemum cinerariaefolium Extract for Use in Biocidal Products of Type 18

The approval of Chrysanthemum cinerariaefolium extract by the EU for type 18 biocides is a significant milestone in the fight against pest insects. This decision will come into effect on February 1, 2025.

The European Union Approves Formic Acid for Biocidal Products: Conditions and Implications

The European Parliament and the Council have approved formic acid as an existing active substance for use in biocidal products of product types 2, 3, 4, and 5, in accordance with Regulation (EU) No. 528/2012. This decision includes formic acid among the approved active substances for biocidal products and comes with specific conditions and considerations aimed at ensuring effectiveness and safety for users, as well as environmental concerns.